Skip to main content
. Author manuscript; available in PMC: 2020 Oct 22.
Published in final edited form as: Clin Cancer Res. 2009 Dec 15;16(1):240–248. doi: 10.1158/1078-0432.CCR-09-0986

Table 3.

Multivariate survival analysis

HR (95% CI) P
Sex (male vs female) 1.64 (1.06-2.65) 0.023*
Stage (I and II vs III and IV) 1.85 (1.21-2.77) 0.005
p-AKT (P vs N) 1.83 (1.11-3.22) 0.016*
p-eIF4E (P vs N) 1.66 (1.15-2.39) 0.006
p-S6 (P vs N) 1.35 (0.92-1.97) 0.126

Abbreviations: HR, hazard ration; 95% CI, 95% confidence interval.

*

P > 0.01.